Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 9/20 | 0.35 |
| ▸ | CNR1 | P21554 | 8/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28577478 | 0.76 | ESR1 (0.43) | NPC1PTGS2 | |
| SCHEMBL18693106 | 0.69 | OPRM1 (0.41) | L3MBTL1NPC1RAB9AOPRM1CNR2 | |
| SCHEMBL1303201 | 0.68 | MARS1 (0.43) | CNR2CNR1 | |
| SCHEMBL3698011 | 0.67 | MAPT (0.49) | L3MBTL1NPC1RAB9ACNR2CNR1 | |
| SCHEMBL28574665 | 0.66 | P2RX7 (0.40) | L3MBTL1NPC1RAB9ACNR2CNR1 | |
| SCHEMBL31125214 | 0.66 | NPC1 (0.51) | NPC1RAB9APTGS2 | |
| SCHEMBL27031354 | 0.66 | PTGS2 (0.55) | PTGS2 | |
| SCHEMBL31125205 | 0.65 | ALDH1A1 (0.57) | L3MBTL1PTGS2 | |
| SCHEMBL3143144 | 0.65 | GLA (0.43) | L3MBTL1NPC1RAB9AOPRM1 | |
| SCHEMBL10362486 | 0.64 | KDM4E (0.50) | L3MBTL1NPC1RAB9AOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112794846-B | Ethyl isoxazoline derivative and application thereof | 宁夏苏融达化工有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-112794846-A | Ethyl isoxazoline derivative and application thereof | 东莞市东阳光农药研发有限公司 | 2021-05-14 | — | — | CN | disclosed |